Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2023

20-01-2023 | Irritable Bowel Syndrome | Invited Commentary

Non-celiac Gluten Intolerance: A Call to Clarify

Authors: Jacqueline Jossen, Benjamin Lebwohl

Published in: Digestive Diseases and Sciences | Issue 4/2023

Login to get access

Excerpt

Interest in consuming a gluten-free diet (GFD) among people who do not carry the diagnosis of celiac disease has risen substantially in the past decade [1]. The many reasons for this increase, which include perceptions that the diet is healthier, promotes weight loss, improves acne, alleviates gastrointestinal symptoms, or is effective as an adjunct treatment for autoimmune diseases, [2, 3] are either unproven or have been refuted [4]. A disease entity termed non-celiac gluten sensitivity (NCGS) was devised to include individuals who perceived a benefit from consuming a GFD. Unlike celiac disease, with well-defined serologic and histologic biomarkers, NCGS is a heterogeneous and poorly-understood condition with diagnostic criteria that can be challenging to measure or confirm in clinical practice [5]. Though very little is known about the contribution of the gluten protein in the pathogenesis of NCGS, there is accumulating evidence that other grain components may be the true culprit in symptom development. …
Literature
1.
2.
go back to reference Arslain K, Gustafson CR, Baishya P, Rose DJ. Determinants of gluten-free diet adoption among individuals without celiac disease or non-celiac gluten sensitivity. Appetite 2021;1(156):104958.CrossRef Arslain K, Gustafson CR, Baishya P, Rose DJ. Determinants of gluten-free diet adoption among individuals without celiac disease or non-celiac gluten sensitivity. Appetite 2021;1(156):104958.CrossRef
3.
go back to reference Passali M, Josefsen K, Frederiksen JL, Antvorskov JC. Current evidence on the efficacy of gluten-free diets in multiple sclerosis, psoriasis, type 1 diabetes and autoimmune thyroid diseases. Nutrients 2020;12(8):2316.CrossRefPubMedPubMedCentral Passali M, Josefsen K, Frederiksen JL, Antvorskov JC. Current evidence on the efficacy of gluten-free diets in multiple sclerosis, psoriasis, type 1 diabetes and autoimmune thyroid diseases. Nutrients 2020;12(8):2316.CrossRefPubMedPubMedCentral
5.
7.
go back to reference Jansson-Knodell CL, White M, Lockett C, Xu H, Shin A. High prevalence of food intolerances among US internet users. Public Health Nutr 2021;24(3):531–535.CrossRefPubMed Jansson-Knodell CL, White M, Lockett C, Xu H, Shin A. High prevalence of food intolerances among US internet users. Public Health Nutr 2021;24(3):531–535.CrossRefPubMed
8.
go back to reference Tavakkoli A, Lewis S, Tennyson C, Lebwohl B, Green PHR. Characteristics of patients who avoid wheat and/or gluten in the absence of celiac disease. Dig Dis Sci 2014;59(6):1255–1261.CrossRefPubMed Tavakkoli A, Lewis S, Tennyson C, Lebwohl B, Green PHR. Characteristics of patients who avoid wheat and/or gluten in the absence of celiac disease. Dig Dis Sci 2014;59(6):1255–1261.CrossRefPubMed
9.
go back to reference Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145(2):320–8.e1-3.CrossRefPubMed Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145(2):320–8.e1-3.CrossRefPubMed
10.
go back to reference Molina-Infante J, Carroccio A. Suspected nonceliac gluten sensitivity confirmed in few patients after gluten challenge in double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol. 2017;15(3):339–348.CrossRefPubMed Molina-Infante J, Carroccio A. Suspected nonceliac gluten sensitivity confirmed in few patients after gluten challenge in double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol. 2017;15(3):339–348.CrossRefPubMed
11.
go back to reference van Megen F, Skodje GI, Lergenmuller S et al. A low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms-a randomized controlled trial. Clin Gastroenterol Hepatol 2022;20(10):2258-2266.e3.CrossRefPubMed van Megen F, Skodje GI, Lergenmuller S et al. A low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms-a randomized controlled trial. Clin Gastroenterol Hepatol 2022;20(10):2258-2266.e3.CrossRefPubMed
12.
go back to reference Skodje GI, Sarna VK, Minelle IH et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology 2018;154(3):529-539.e2.CrossRefPubMed Skodje GI, Sarna VK, Minelle IH et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology 2018;154(3):529-539.e2.CrossRefPubMed
13.
go back to reference Zevallos V, Raker V, Tenzer S, Schild H, Steinbrink K, Schuppan D. Nutritional wheat amylase-trypsin inhibitors promote intestinal inflammation via activation of myeloid cells. Gastroenterology 2017;152(5):1100–1113.CrossRefPubMed Zevallos V, Raker V, Tenzer S, Schild H, Steinbrink K, Schuppan D. Nutritional wheat amylase-trypsin inhibitors promote intestinal inflammation via activation of myeloid cells. Gastroenterology 2017;152(5):1100–1113.CrossRefPubMed
Metadata
Title
Non-celiac Gluten Intolerance: A Call to Clarify
Authors
Jacqueline Jossen
Benjamin Lebwohl
Publication date
20-01-2023
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07802-3

Other articles of this Issue 4/2023

Digestive Diseases and Sciences 4/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.